Our Businesses – MDS Analytical Technologies

Overview
A global leader focused on the research, design, manufacture and marketing of state-of-the-art solutions for mass spectrometry, drug discovery and bioresearch. Customers count on MDS Analytical Technologies’ products to help accelerate the complex process of discovering and developing new drug compounds, understand the causes of disease, and protect the safety of food, water and the environment.

Market Segments Mass spectrometers for life sciences and applied markets Drug discovery Bioresearch

Key 2008 Achievements and Improvements

• Launched significant new instruments and software products, including:
  • AB SCIEX Triple Quad™ 5500 and AB SCIEX QTRAP^® 5500 mass-spectrometry systems
  • Axon GenePix^® 4300A and 4400A Systems
  • ArcturusXT™ System
  • CellKey™ 384 System
  • Analyst^® 1.5 software
  • iMethod™ for Cliquid^® software
  • DiscoveryQuant™ software
• Acquired Blueshift Biotechnologies.
• Transferred key manufacturing capabilities from North America to Asia.

			Key 2009 Priorities Launch innovative products from all lines of business. Expand global sales and service organizations in high growth markets and regions, with a focus on Asia. Accelerate the transfer of manufacturing capabilities to Asia and maximize the Asian supply chain.